What it is
IGF-1 DES at a glance
Truncated IGF-1 analog lacking N-terminal tripeptide
Shorter IGF-1 analog has altered receptor/binding behavior and potent local signaling in models.
View supplier listing
15% off with code KING15
Peptide guide
IGF-1 DES Peptide Guide & Supplier Listing Notes
Truncated IGF-1 analog lacking N-terminal tripeptide
Shorter IGF-1 analog has altered receptor/binding behavior and potent local signaling in models.
Educational disclaimer
Informational reference only
This page is for educational and informational purposes only. PeptideSuppliers.org does not sell peptides, provide medical advice, or recommend human use.
Research context
Where current research places it
IGF signaling, muscle/growth-factor cell and animal models
Mostly preclinical/research reagent use
Research overview
Use the linked literature searches for current papers and trial records.
Current summary
What research has looked at
Shorter IGF-1 analog has altered receptor/binding behavior and potent local signaling in models.
Evidence stage
How mature the research is
Mostly preclinical/research reagent use
Source links
Open current literature searches
Mechanism
Why removing three amino acids changes the picture
IGF-1 DES (des(1-3)IGF-1) is native IGF-1 with its first three N-terminal amino acids removed. That modification reduces its binding affinity to IGF-binding proteins, which are the proteins that normally regulate how much free IGF-1 is available in circulation.
The proposed result is greater local, unbound biological activity compared with native IGF-1, which makes IGF-1 DES a research tool for studying IGF-1 receptor signaling somewhat independent of the binding-protein system, rather than a general-purpose growth-factor product.
Storage and handling notes
What clear supplier pages show
These pages are easier to trust when storage notes are easy to find, the format is clearly labeled, and batch documentation stays close to the listing.
- Check whether the page clearly states the compound format being referenced.
- Look for storage language that matches the label and any linked laboratory documentation.
- Compare whether lot, batch, or COA references remain easy to access after the product details.
- Note whether the page explains container, seal, or light-protection details in plain language.
Choosing a supplier page
What to compare when opening listings
A strong page should identify the variant precisely, keep the growth-signaling context readable, and make documentation notes easy to compare.
IGF-1 DES pages work better when they distinguish the variant clearly and keep the supporting notes more specific than the category headline.
Linked supplier pages
Use these pages to compare naming, documentation access, and overall page clarity.
Supplier listing
Peptides Kingdom
This listing is useful for checking naming, documentation access, and overall page clarity.
15% off with code KING15Frequently asked questions
Quick answers to the main questions that come up on this page.
What is IGF-1 DES?
Truncated IGF-1 analog lacking N-terminal tripeptide
What research areas is it linked to?
IGF signaling, muscle/growth-factor cell and animal models
Mostly preclinical/research reagent use
What should stand out when comparing supplier pages?
A strong page should identify the variant precisely, keep the growth-signaling context readable, and make documentation notes easy to compare.
How is IGF-1 DES different from IGF-1 LR3?
Both are modified to reduce interaction with IGF-binding proteins, but through different structural changes: IGF-1 DES removes N-terminal amino acids, while IGF-1 LR3 adds an extended R3 sequence.
Is IGF-1 DES used outside research settings?
No. It is treated as a laboratory reagent and research compound, not an approved product.